Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

Allow me to reiterate...


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147745017

It is important to note that this report is not applicable to isradipine, which is a truly unique situation. This will not be an FDA regulatory decision. The research was not sponsored by Elite, and Elite will not be mentioned in association with the research results. I am not sure the market will appreciate the connection between ELTP and STEADYPD-III, at least until it hits an earnings report. Good results will be good for Elite, the old-fashioned way, by selling more product in response to increased demand. I'll take that all day, but I continue to urge for tempered expectations regarding an immediate effect of isradipine news, even great news.

When the results are announced, Elite will not be mentioned. There is very little reason to expect a big market reaction to isradipine news for ELTP stock, even after results are announced. And there is *ZERO* reason to believe we should be able to divine the STEADY results based on current ELTP action. The idea is not just silly, it is stupid. I continue to have great expectations for the STEADY results, but I do not expect ELTP share price to be any higher on May 8 than it was on May 6.